Viatris (VTRS) Net Income towards Common Stockholders Growth (5y) (2024 - 2026)
Powered by 
Analysis
Viatris (VTRS) Net Income towards Common Stockholders Growth (5y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.60 Bn | 38.94 Bn | 2.15 Bn |
| 2 | Viatris | 19.15 Bn | 18.27 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.35 Bn | 516.55 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 996.17 Mn | 706.05 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.39 Mn | 363.15 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.71% |
| Mar 31, 2026 | 16.76% |
| Dec 31, 2025 | 17.97% |
| Sep 30, 2025 | 5.38% |
| Jun 30, 2025 | -38.58% |
| Mar 31, 2025 | -171.77% |
| Dec 31, 2024 | -100.92% |